טוען...
Risk of low bone mineral density in patients with rheumatoid arthritis treated with biologics
BACKGROUND: Osteoporosis is a complication of rheumatoid arthritis (RA). We identified risk factors for osteoporosis during treatment with biologics. METHODS: Femoral neck bone mineral density (BMD) was measured in 186 patients with biologics-treated RA. We compared the characteristics of those with...
שמור ב:
| הוצא לאור ב: | BMC Musculoskelet Disord |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4589107/ https://ncbi.nlm.nih.gov/pubmed/26420629 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-015-0732-x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|